SCHEMBL1075378

SCHEMBL1075378

COc1cc(F)c(-c2c(Cl)nc(C)n2-c2ccc(I)cc2)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
TSHR P16473 2/20 0.33
HTT P42858 2/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
NPBWR1 P48145 1/20 0.33
MCHR1 Q99705 1/20 0.33
MAPK1 P28482 2/20 0.33
GAA P10253 2/20 0.33
ALDH1A1 P00352 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GRM8 O00222 1/20 0.33
CYP1A2 P05177 1/20 0.33
GRM7 Q14831 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1110867 0.91 PIK3CA (0.40) PIK3CAPTGS1PTGS2SMN1; SMN2TSHR
SCHEMBL1073735 0.90 SMN1; SMN2 (0.41) PIK3CASMN1; SMN2TSHRHTTLMNA
SCHEMBL1076571 0.90 SMN1; SMN2 (0.38) PIK3CAPTGS1PTGS2SMN1; SMN2TSHR
SCHEMBL1225381 0.90 PIK3CA (0.42) PIK3CAPTGS1PTGS2SMN1; SMN2TSHR
SCHEMBL1074241 0.86 SMN1; SMN2 (0.36) PTGS1PTGS2SMN1; SMN2TSHRHTT
SCHEMBL1074053 0.85 GRM1 (0.40) PTGS1PTGS2SMN1; SMN2TSHRHTT
SCHEMBL1110806 0.85 MPO (0.34) PIK3CAPTGS1PTGS2SMN1; SMN2TSHR
SCHEMBL2448152 0.83 PIK3CA (0.35) PIK3CAPTGS1PTGS2SMN1; SMN2TSHR
SCHEMBL2451262 0.83 PIK3CA (0.35) PIK3CAPTGS1PTGS2SMN1; SMN2TSHR
SCHEMBL2451452 0.82 OXTR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011056463-A2 FUNGICIDAL MIXTURES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-05-12 WO disclosed
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-24 US disclosed
EP-2274284-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. Du Pont de Nemours and Company (US) 2011-01-19 EP disclosed
WO-2009137538-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed
WO-2009137651-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES CBR3, NOX3, CBR1 PIK3CA 528/4885PTGS1 3823/4885PTGS2 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.